| Name | Title | Contact Details | 
|---|---|---|
| David Lubarsky | President and CEO | Profile | 
| Valerie Campbell | Regional Vice President of Compliance | Profile | 
| Braulio Carrero | Associate General Counsel | Profile | 
| Anu Paulose | Assistant General Counsel | Profile | 
| Christopher Librandi | Senior Associate General Counsel | Profile | 
Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX) is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company`s current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL® (bupivacaine liposome injectable suspension), was commercially launched in the United States in April 2012. EXPAREL and two other products have utilized the Pacira proprietary product delivery technology DepoFoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time.
Ability Services Network Inc is a Duluth, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Canadian Dental Service Plans Inc. is a North York, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
PRS Network is a Larkspur, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Park Place Behavioral Health Care is a Kissimmee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.